Literature DB >> 31950540

Circ_LAS1L regulates cardiac fibroblast activation, growth, and migration through miR-125b/SFRP5 pathway.

Li-Ye Sun1, Jin-Chao Zhao2, Xiao-Ming Ge3, Hui Zhang4, Chuan-Mei Wang4, Zi-Dong Bie4,5.   

Abstract

Current studies have shown that circular RNAs (circRNAs) and microRNAs (miRNAs) are closely related in acute myocardial infarction (AMI). Previous studies have shown that miR-125b promotes fibrosis and up-regulates in cardiac fibroblasts (CFs), and further experiments showed that circ_LAS1L had multiple binding sites of miR-125b, and their expression was inversely related in AMI patients and CFs. RNA immunoprecipitation (RIP), pull down, and dual luciferase reporter gene assay all confirmed that miR-125b directly bound to circ_LAS1L. Circ_LAS1L overexpression promoted the expression of downstream target gene secreted frizzled-related protein 5 (SFRP5), inhibited the expression of alpha-SMA, collagen I, and collagen III, inhibited CF proliferation and migration, and promoted apoptosis. When cotransfected with circ_LAS1L overexpression vector and miR-125b mimics, the above gene expression and CF biological behaviours did not change significantly. But when cotransfected with circ_LAS1L overexpression vector and SFRP5 siRNA, SFRP5 expression was still down-regulated, the expression of alpha-SMA, collagen I, and collagen III was up-regulated, and the proliferation and migration of CFs were increased. Therefore, circ_LAS1L inhibits the activity of miR-125b by adsorbing it, thus promoting the expression of SFRP5 and then regulating the biological characteristics of CFs. These findings may provide an important experimental basis for the regulation of myocardial fibrosis after myocardial infarction. SIGNIFICANCE OF THE STUDY: Studies have shown that circular RNAs (circRNAs) play important roles in cardiovascular diseases, but there are few studies on their roles in the process of myocardial fibrosis. In this study, we found that circ_LAS1L was down-regulated in acute myocardial infarction (AMI) patients and cardiac fibroblasts (CFs), and could bind directly to miR-125b, thereby promoting the expression of downstream target gene secreted frizzled-related protein 5 (SFRP5), ultimately inhibiting the activation, proliferation and migration of CF, and promoting apoptosis. This suggests that circ_LAS1L/miR-125b/SFRP5 pathway can regulate the biological function of CF and may play an important role in the process of myocardial fibrosis, thus providing an important theoretical basis for the regulation of myocardial fibrosis after myocardial infarction.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  SFRP5; cardiac fibroblast; circRNA; miR-125b; myocardial infarction

Mesh:

Substances:

Year:  2020        PMID: 31950540     DOI: 10.1002/cbf.3486

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  11 in total

Review 1.  Insights into circular RNAs: their biogenesis, detection, and emerging role in cardiovascular disease.

Authors:  Zoe Ward; John Pearson; Sebastian Schmeier; Vicky Cameron; Anna Pilbrow
Journal:  RNA Biol       Date:  2021-03-28       Impact factor: 4.652

Review 2.  Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.

Authors:  Yuncong Shi; Huanji Zhang; Suli Huang; Li Yin; Feng Wang; Pei Luo; Hui Huang
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

Review 3.  Circulating Circular RNAs: Novel Biomarkers for Heart Failure.

Authors:  Chuan Sun; Mingming Ni; Bo Song; Lu Cao
Journal:  Front Pharmacol       Date:  2020-11-13       Impact factor: 5.810

4.  CREG ameliorates the phenotypic switching of cardiac fibroblasts after myocardial infarction via modulation of CDC42.

Authors:  Dan Liu; Xiaoxiang Tian; Yanxia Liu; Haixu Song; Xiaoli Cheng; Xiaolin Zhang; Chenghui Yan; Yaling Han
Journal:  Cell Death Dis       Date:  2021-04-06       Impact factor: 8.469

Review 5.  Circular RNAs and Cardiovascular Regeneration.

Authors:  Ling Tang; Pengsheng Li; Michelle Jang; Wuqiang Zhu
Journal:  Front Cardiovasc Med       Date:  2021-04-13

Review 6.  Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics.

Authors:  Jinhong Chen; Zhichao Liu; Li Ma; Shengwei Gao; Huanjie Fu; Can Wang; Anmin Lu; Baohe Wang; Xufang Gu
Journal:  Front Genet       Date:  2021-12-20       Impact factor: 4.599

Review 7.  MiR-125 Family in Cardiovascular and Cerebrovascular Diseases.

Authors:  Yang Wang; Jing Tan; Lu Wang; Gaiqin Pei; Hongxin Cheng; Qing Zhang; Shiqi Wang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Front Cell Dev Biol       Date:  2021-12-02

Review 8.  Circle the Cardiac Remodeling With circRNAs.

Authors:  Tiqun Yang; Tianxin Long; Tailai Du; Yili Chen; Yugang Dong; Zhan-Peng Huang
Journal:  Front Cardiovasc Med       Date:  2021-06-25

Review 9.  Circular RNAs as Competing Endogenous RNAs in Cardiovascular and Cerebrovascular Diseases: Molecular Mechanisms and Clinical Implications.

Authors:  Xue Min; Dong-Liang Liu; Xing-Dong Xiong
Journal:  Front Cardiovasc Med       Date:  2021-07-07

Review 10.  Non-coding RNAs in cardiac regeneration: Mechanism of action and therapeutic potential.

Authors:  Yi Wang; Jinghai Chen; Douglas B Cowan; Da-Zhi Wang
Journal:  Semin Cell Dev Biol       Date:  2021-07-17       Impact factor: 7.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.